New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company